about
MRTF-A steers an epigenetic complex to activate endothelin-induced pro-inflammatory transcription in vascular smooth muscle cellsMicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth.Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia modelAggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription.Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury.Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-β signaling.MKL1 potentiates lung cancer cell migration and invasion by epigenetically activating MMP9 transcription.A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy.Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy.Angiogenic factor with G patch and FHA domains 1 (Aggf1) promotes hepatic steatosis in mice.HIC1 epigenetically represses CIITA transcription in B lymphocytes.Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β signaling.HDAC4 mediates IFN-γ induced disruption of energy expenditure-related gene expression by repressing SIRT1 transcription in skeletal muscle cells.Aggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription.MiR-144 regulates hematopoiesis and vascular development by targeting meis1 during zebrafish development.Meta-analysis identifies robust association between SNP rs17465637 in MIA3 on chromosome 1q41 and coronary artery disease.MKL1 is an epigenetic modulator of TGF-β induced fibrogenesis.
P50
Q34249545-941BD00E-8640-48D9-B923-26E4381F54A2Q34324565-08BE3A7F-31E7-440D-ADD6-7734ACD1F61DQ34460354-22FB5A83-FE8F-46D8-8AAC-244472C1AC14Q38624966-3421BDE4-9433-4BA5-B9E4-5C00C9D4EAF6Q38718223-778ABF3A-1BFC-40A9-9F6D-E95F967A7DBAQ38809837-1322E5EA-F89C-46A2-9884-1FB5A241E617Q38902929-56D1113A-32D7-4E84-847A-1480EE7FB3C9Q38906301-315D1C56-AC08-4454-8AE9-0C8F6828D2D5Q38935695-5998FC3E-C555-4725-8A5C-95C2E0A3F821Q39171757-54C85233-11EF-4729-82EB-23683928F698Q39308151-1DCC13C3-AA53-4528-96AC-53F20333F8F6Q40019216-3BCEDD6E-D8CA-4263-B38F-0E186F61F3B7Q40260871-FB07A3E4-2EAB-4E96-994F-669E97DBF390Q47139935-FFD79903-9A66-4DA9-B222-5E9678EF06DFQ50463179-CB85D571-184B-49E1-B82C-0096A6D44C5BQ54762809-71754036-5B9B-4CDA-857E-5642F5E7D154Q55051381-282DCA2E-A792-4B3D-9F88-59199A8ED97A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bisheng Zhou
@ast
Bisheng Zhou
@en
Bisheng Zhou
@es
Bisheng Zhou
@nl
type
label
Bisheng Zhou
@ast
Bisheng Zhou
@en
Bisheng Zhou
@es
Bisheng Zhou
@nl
prefLabel
Bisheng Zhou
@ast
Bisheng Zhou
@en
Bisheng Zhou
@es
Bisheng Zhou
@nl
P108
P106
P31
P496
0000-0003-1551-0612